Followers | 2565 |
Posts | 299966 |
Boards Moderated | 29 |
Alias Born | 04/12/2001 |
Thursday, February 15, 2024 7:47:21 PM
We do have rules about naked shorting. They're called Regulation SHO, and initially became effective in early 2005. They were then amended to make them more comprehensive in 2007.
https://www.sec.gov/rules/2004/07/short-sales#:~:text=Regulation%20SHO%20defines%20ownership%20of,the%20Commission%20to%20suspend%20temporarily
And this, updated in 2022, is more digestible:
https://www.sec.gov/investor/pubs/regsho.htm
Reg SHO worked. The SEC finds mismarked tickets now and then, and punishes the perps. But "NSS" isn't a problem successful companies complain about. Usually, the real problem is toxic funders. The guys who buy promissory notes that convert at an enormous discount to market, and then dump them on the market. The notes are also known as "death spiral convertibles".
See you tomorrow!
Recent RENB News
- Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics • GlobeNewswire Inc. • 04/30/2024 03:00:00 PM
- RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership • GlobeNewswire Inc. • 04/24/2024 01:00:00 PM
- Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Ca • GlobeNewswire Inc. • 04/18/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:03:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 08:20:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:01:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:35:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:17:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:20:42 PM
- Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace • GlobeNewswire Inc. • 02/15/2024 02:25:00 PM
- Statement of Renovaro Inc • GlobeNewswire Inc. • 02/14/2024 03:01:30 PM
- Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace • GlobeNewswire Inc. • 02/13/2024 02:46:07 PM
- AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine • GlobeNewswire Inc. • 02/13/2024 02:31:09 PM
- Renovaro Biosciences Announces Results of Special Meeting of Shareholders • GlobeNewswire Inc. • 01/25/2024 05:45:00 PM
- Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors • GlobeNewswire Inc. • 10/11/2023 01:25:00 PM
- Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors • GlobeNewswire Inc. • 10/10/2023 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:34:03 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 10/06/2023 08:30:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:20:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:15:17 PM
- Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD • GlobeNewswire Inc. • 10/02/2023 04:05:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM